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1Chapter
EUS-B for the Interventional 
Pulmonologist Using the EBUS 
Scope in the Esophagus
Yousef R. Shweihat and Shantanu Singh
Abstract
This chapter aims at introducing the interested Pulmonologist/Interventional 
Pulmonologist to the esophageal ultrasound. In this chapter, we give short descrip-
tions of some technical aspects of the endobronchial ultrasound (EBUS) scope and 
explain in detail why we believe the EBUS scope is well suited to be an esophageal 
scope in the hands of the trained pulmonologist. The chapter then explains indica-
tions and benefits of this procedure that we consider central to the practice of chest 
physicians. We also describe in steps how to reach each lymph node station using 
the EBUS scope as a EUS scope (EUS-B) from our own experience. Procedure-
related complications and contraindications are also described.
Keywords: esophageal ultrasound, endobronchial ultrasound, lymph node stations
1. Introduction
Interventional pulmonary has witnessed substantial growth in the past few 
years. A major factor in the growth has been the advent of endobronchial ultra-
sound (EBUS) as a staging modality for lung cancer and as a diagnostic tool for 
diseases with mediastinal involvement. The development of EBUS was preceded by 
esophageal ultrasound (EUS), and the literatures on both techniques have grown 
in parallel. More recently, the efficacy and utility of an esophageal approach using 
the EBUS scope (EUS-B) has been described to access nodes and masses acces-
sible during a single sedation to more accurately diagnose and stage disease either 
via tracheal or esophageal route. Here, we describe relevant anatomy, procedural 
techniques, indications, contraindications, and complications for EUS-B.
2. Technical aspects
2.1 EBUS bronchoscope
EBUS can refer to two distinct types of probes/scopes. Radial probe EBUS is 
the first type, and was commercially available in 1992. It increased the yield of 
transbronchial needle aspiration of mediastinal lymph nodes and is currently used 
mainly to biopsy peripheral nodules or examines the different central airways 
diseases. The second type is the convex/curvilinear probe EBUS bronchoscope. 
It was introduced in 2002 and commercialized around 2004. In this chapter, our 
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discussion is limited to the most widely available curvilinear scope manufactured 
by multiple companies (Olympus, Fuji, and Pentax) with minimal differences 
in characteristics. The differences between scopes are beyond the scope of this 
text. The reader is encouraged to be familiar with the specifications of the scopes 
and their relative US processors available at his/her institution. Some features 
are worth mentioning though which are big difference between the EBUS and 
conventional EUS scopes. The working tube of about 60 cm is much shorter than 
the EUS. The largest intubating diameter at the tip of the EBUS scopes ranges from 
6.7 to 7.4 mm. The remainder of the insertion tubes has a diameter of 6.3–6.4 mm. 
The working channel diameter is from 2.0 to 2.2 mm. The ultrasonic transducer is 
situated at the tip of the bronchoscope just distal to the video camera, light source, 
and the working channel aperture. It emits ultrasonic waves that range from 5 to 
12 MHz, and this depends on the ultrasound processor used and settings selected. 
The ultrasonic scanning range obtained via these scopes is triangular in shape and 
yields a 60–75° view parallel to the insertion tube. The tissue depth of ultrasonic 
views and focusing capabilities can be altered and varies according to the ultra-
sound processor used. Multiple manufacturers offer single-use aspiration needles 
available in 19G, 21G, and 22G with excellent puncture capability under ultrasonic 
view. The design improves visibility on ultrasound images to enable a precise 
puncture. After loading and securing the needle in the working channel, the needle 
extends out of the channel and intersects with the ultrasonic view enabling the 
endoscopist to control the depth and location of needle insertion into the lymph 
node in a real time fashion.
2.2 Why the EBUS scope, not the EUS scope?
The EBUS scope is different in many ways from its counterpart used in the GI 
tract. First, the diameter is almost half of any available ultrasound endoscope. In 
our opinion, this makes the bronchoscope more comfortable for the patient, and 
reduces sedation requirement. Second, the control part of the bronchoscope has 
fewer controllers making it easier for the pulmonologist to handle. It is a design that 
they are used to and comfortable using with no need for extra training to be able 
to handle it. This in our opinion shortens the learning curve. Third, it enables the 
thoracic physician to completely evaluate the mediastinum in one session using one 
piece of equipment. This minimizes the costs of additional equipment and need 
for additional procedure without compromising on patient management. Fourth, 
the EBUS scope is shorter than the EUS scope, thus enhancing maneuverability. 
This shorter length is well suited for sampling thoracic and mediastinal structures. 
Sampling of the pancreas or abdominal lymph nodes is out of the scope and exper-
tise of most thoracic physicians. Added length of the EUS scope does not offer 
additional advantage to a practicing pulmonologist.
3. Indications
One of the major advances in the treatment of lung cancer is the advent of 
non-surgical pathologic staging using EBUS. The combination of EBUS and EUS 
for sampling of mediastinal nodes allows near complete staging of the mediastinum 
[1–3], which is equivalent, if not superior to mediastinoscopy in experienced hands 
[4, 5]. Multiple studies showed the EBUS scope efficacious in serving the EUS scope 
role (EUS-B) [6, 7]. The added benefit of the esophageal access in staging lung can-
cer comes from its ability to reach and locate lymph nodal stations that are impos-
sible to reach via the airways such as stations 3p, and paraesophageal lymph nodal 
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stations 8 and 9 (see Table 1 for lymph node stations accessible by EBUS and EUS). 
Given the literature on combined EBUS and EUS, it can be argued that EBUS and 
EUS-B should be performed at the same time for all patients with suspected lung 
cancer at institutions where rapid on-site cytologic evaluation is not available. This 
approach is recommended by the European Society of Gastrointestinal Endoscopy 
(ESGE) and European Respiratory Society (ERS) guidelines [8]. The utility of 
EBUS and EUS-B is not limited to staging or diagnosis of lung cancer. The EBUS 
has well documented advantages in diagnosing mediastinal lymphoma [9–11], 
sarcoidosis [12–14], tuberculosis [15, 16], pulmonary parenchymal masses [17, 18], 
and metastatic disease to the mediastinum [19], among others including infec-
tions [9, 20]. EUS-B has the same ability to investigate the mediastinum when such 
conditions are suspected, since the utility of EUS is well documented in such disease 
states [21, 22]. In addition, instances where a mediastinal mass or lymphadenopathy 
is paraesophageal and paratracheal, the esophageal approach might be preferred, 
especially when there is difficulty to access the airway due to patient intolerance 
or if accessing the airway predisposes increase risk to hypoxemic, intubated, and 
critically ill patients [23]. The indications for EUS-B are summarized in Table 2.
Lymph node station EBUS EUS-B
1 + −
2R + +
2L + +
3a − −
3p − +
4R + −
4L + +
5 − +
6 − *
7 + +
8 R,L − +
9 R,L − +
10–12 R,L + −
*reported using EUS but not EUS-B.
Table 1. 
Lymph nodes accessible by EBUS vs. EUS-B.
Indications for EUS-B
Lung cancer staging, stations 3p, 8, 9, 5, and 4L and 7
Paraesophageal abnormalities not accessible via the airways
Mediastinal masses that can be approached through airway and esophagus, esophagus is preferred for patient 
comfort
Sampling mediastinal lymphadenopathy of any etiology
Mediastinal pathology in critically ill or intubated patients
Sampling and drainage of mediastinal cysts
Bleeding diathesis (see text)
Table 2. 
Indications for EUS-B.
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Figure 1. 
After bypassing the epiglottis, to enter the esophagus, the scope needs to be placed behind the left arytenoid. 
Vision will cease after that point and US vision should be used to assist locating the probe position in the 
esophagus. Note: gentle pressure with some corkscrew or alternating mild upward and downward movements 
on the scope lever will assist in entering the esophagus.
4. Anesthesia
EBUS bronchoscopy is carried out under either conscious sedation or general 
anesthesia with laryngeal mask airway (LMA) or intubation. EUS/B can be per-
formed in the same setting under general anesthesia or conscious sedation. Patient 
tolerance seems to be adequate when conscious sedation is used [24]. Multiple drug 
regimens are available for conscious sedation. We do not recommend one regimen 
over the other. Local expertise, hospital policies, availability of an anesthesia team, 
and costs govern the types of sedatives and techniques used. Institutional protocols 
should be developed and followed to ensure safety of procedures. Even when LMA 
is used, EUS-B can still be performed in the same setting as described below. This 
is one benefit of EUS-B over conventional EUS. It is important to mention in this 
setting that endotracheal intubation is not prohibitive of performing EUS-B and is 
actually an indication as mentioned earlier. In the intubated and/or the critically ill 
patient, EUS-B allows us the easiest and sometimes the only access to mediastinal 
pathology. It is our experience that this approach does not require more sedation 
than required for mechanical ventilation.
5. Insertion techniques for EUS-B
It is necessary to intubate the oral cavity (as opposed to the nares) when using 
the EBUS scope. A “bite block” (in cases of intubation, in ICU and conscious 
sedation) should be used to protect the scope from potential damage from a bite if 
LMA is not used. An added oropharyngeal airway, such as the Williams airway, can 
facilitate passage of the scope into the supraglottic/posterior pharyngeal space and 
offer further protection to scope under conscious sedation.
When conscious sedation or endotracheal (ET) tube is used and once in the 
posterior pharyngeal space, the scope can be advanced into the esophagus using two 
basic techniques. The first “blind” technique involves holding the scope with the 
ultrasound transducer facing the posterior pharynx. Patient is instructed to swallow 
after instillation of topical lidocaine or saline. Once the patient starts swallowing, the 
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scope can be advanced with gentle pressure, allowing the peristaltic wave to carry it. 
Rapid minor alternating flexion and release of the scope using the control lever can 
aid passage of the scope into the esophagus. If the blind technique fails, the scope can 
be passed under direct visualization. The scope can be inserted with the transducer 
(and visual field) facing anteriorly. Once in the posterior pharynx, the tip can be ret-
roflexed and the larynx visualized. The tip of the scope can then be passed posterior 
to the arytenoids and to left with gentle pressure, see Figure 1. If resistance is faced, 
the scope can be withdrawn and another attempt on the right side or midline can be 
tried. It is important not to use excessive pressure if the scope does not pass easily. A 
gentle corkscrew maneuver with gentle advancement is all that is required.
The use of the LMA is prohibitive of using the conventional EUS scope but not 
the EUS-B. The LMA inherently obstructs the esophageal opening. Once the EBUS 
scope is at the level of the larynx, the tip is pointed and scope placed behind the left 
arytenoid. An assistant is asked to perform a jaw thrust maneuver that will elevate 
the laryngeal structures and give enough space for the small EBUS scope to be gen-
tly passed into the esophagus. Once in the esophagus, the jaw thrust can be stopped 
and procedure is continued. In our experience, with over 500 EUS-B procedures, we 
have not experienced failure or a complication passing the scope into the esophagus 
using any of these techniques.
6. Anatomic landmarks and organs studied
In contrast to EBUS in the airways, EUS-B relies entirely upon ultrasonic images 
for localization; the esophagus has no internal landmarks for nodal mapping. 
Because of this, lymph node stations are identified and numbered based upon their 
relationships with other structures “seen” ultrasonographically through esopha-
geal wall. In addition, interpersonal variability exists between patients, and large 
mediastinal tumors or abnormalities can alter the normal anatomy and displace or 
compress the esophagus or other structures, thus altering the ultrasonic views and 
anatomic relations. A computerized tomographic scan is almost invariably avail-
able. It is advised that the endoscopist carefully review patient anatomy prior to and 
during the procedure to avoid sampling normal structures.
The mediastinal structures that can be normally seen and examined on EUS-B are:
1. Cardiac structures: left atrium, left ventricle, aortic valve, mitral valve, 
pericardium
2. Thoracic aorta: descending, arch, root
3. Pulmonary vessels: left pulmonary artery, right pulmonary artery
4. Vertebral bodies
5. Mediastinal pleura and pleural effusion if large enough
6. Mediastinal lymph nodes
7. Liver
During the initial training for EUS, it is important to define a point of refer-
ence that the endoscopist can refer to during the procedure. In our practice, we 
first identify the left atrium as a point of reference. The scope is advanced into 
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the esophagus with the ultrasound transducer facing anteriorly until the atrium 
can be identified. The atrium is easily identified due to its shape, its pulsating 
nature, and great variability in size (compared to the great vessels) with contrac-
tions (Figure 2, also see Video at https://mts.intechopen.com/download/index/
process/324/authkey/bb9c02ba5640a4d21d4511e0a79f3621). A thin paper-like 
echogenic structure can usually be observed moving inside of this anechoic 
sac (of blood), this is the mitral valve (Figure 3, also see Video at https://mts.
intechopen.com/download/index/process/324/authkey/bb9c02ba5640a4d-
21d4511e0a79f3621). If the patient is in atrial fibrillation, this pulsating charac-
teristic is lost, but the mitral valve movement can still be identified that helps 
localizing the atrium. In most instances, a slight rotation to the left is necessary 
to identify the atrium and mitral valve. The depth of field of the ultrasonic 
view can be altered. We usually leave it at 4 cm, but if in doubt, the depth of the 
ultrasonic view can be increased to 7.5 cm, and this will allow viewing the left 
Figure 3. 
Moving distally with slight rotation to left and increased depth can show the mitral valve (blue arrow) under 
the LA (white circle).
Figure 2. 
At 3–4 cm depth (dashed green), the left atrium (green arrow) can be seen looking anteriorly. Increasing the 
depth to 5–7 cm and slight rotation can identify the aortic valve (red arrow), root (orange star), and outflow 
tract from left ventricle (blue x).
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ventricle and mitral valve and atrium easily. When using the increased depth 
on the ultrasonic view, the root of the aorta and the aortic valve are also easily 
identifiable (Figure 2, also see Video at https://mts.intechopen.com/download/
index/process/324/authkey/bb9c02ba5640a4d21d4511e0a79f3621). It is neces-
sary to mention here that slight variability exists between patients and moving 
the scope inferiorly and superiorly or small rotations are necessary to identify all 
of these structures. The pericardium is an echoic membrane that is almost always 
separated from the left atrium by a rim of physiologic effusion in this view (a 
dependent area just posterior to the left atrium in the supine position). When 
this effusion is big, it can create some confusion to the endoscopist. It is always 
important to identify the pericardium to avoid puncturing it. Rarely, a mediasti-
nal cyst can occur in this position, which can make the views confusing. Again, 
increasing the depth on the US screen will help to identify cardiac versus non-
cardiac structures. In addition, the use of real time color Doppler will help to 
separate a cystic structure from a vascular structure, see Figure 2. The liver can 
also be noted and inferior vena cava can be examined too at the distal esophagus 
just before entering the stomach (Figure 4, Video at https://mts.intechopen.com/
download/index/process/324/authkey/bb9c02ba5640a4d21d4511e0a79f3621).
6.1 Lymph node stations
In this section, we describe the anatomic definitions according to the eight edi-
tion of “Lung Cancer Staging Manual” [25]. We describe “how to reach” the lymph 
nodal stations, according to our practice. The EUS-B maneuver starts from our 
point of reference, i.e., the left atrium, in each of the descriptions stated below.
6.1.1 Station seven lymph nodes
Anatomic definition:
Mediastinal node limited by the carina superiorly and upper border of lower 
lobe bronchus on the left and lower border of the bronchus intermedius on  
the right.
Conventional name:
Subcarinal lymph nodes.
Figure 4. 
At the lower end of the esophagus, looking to the right and anteriorly, one can identify the IVC (Yellow star) 
and liver (red X); the liver also can be seen anteriorly after the scope is passed distally.
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EUS location:
This station can be located by slightly pulling the scope rostral above the level of 
atrium. A slight right or left rotation of the scope is necessary to choose the optimal 
view of the lymph node and avoid puncturing the great vessels. At the level of station 
seven, the right pulmonary artery can be identified crossing to the other side of the 
mediastinum (just deeper to the lymph node on the ultrasound screen, see Figure 5).
6.1.2 Stations 8 and 9
Anatomic definition:
Station 8: superiorly limited by the upper border of lower lobe bronchus on the 
left and lower border of the bronchus intermedius on the right and extends down to 
the diaphragm.
Station 9: superiorly limited by the inferior pulmonary vein and extends down to 
the diaphragm. These lymph nodes are located within the pulmonary ligament.
Conventional name:
8: Paraesophageal lymph nodes.
9: Pulmonary ligament lymph nodes.
EUS location:
They are identified by rotating the scope right or left with gently moving it caudally.
Station 9 is identified as any node that associated (in close proximity to) the infe-
rior pulmonary vein and are within the pulmonary ligaments. Station 9 lymph nodes 
can extend in the pulmonary ligament to the diaphragm, but the only “visible” part 
of the station is at the junction of the inferior pulmonary vein with the left atrium.
Station 8 lymph nodes are paraesophageal lymph nodes. The upper border is 
difficult to localize precisely by EUS but in general are the nodes that are on either 
side of the esophagus below the superior border of the left atrium and extend down 
to the level of the diaphragm. Of note, both superior pulmonary veins and inferior 
pulmonary vein on the right are not always identifiable, the left inferior pulmonary 
vein is almost always identifiable on EUS-B and serves as a landmark for both sides 
of the mediastinum; it identifies the pulmonary ligament. It is hard to differentiate 
between level 9 and level 8 near the level of the inferior pulmonary vein. The clini-
cal significance of this differentiation is almost nil, since the presence of metastasis 
to these lymph nodes from a primary lung cancer indicates N2 if on same side or N3 
if the primary cancer is on the other side.
Figure 5. 
Rostrally from Figure 2. White arrow shows the pericardial recess, and the diamond is the right pulmonary 
artery crossing the mediastinum. Note: a slight rotation right will show part of station 7 LN (green arrow).
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6.1.3 Station 4L
Anatomic definition:
Extends to the upper limits of the aortic arch and down to upper rim of the left 
main pulmonary artery.
Conventional name:
Left lower paratracheal lymph nodes.
EUS location:
This can be reached with either of two techniques. First, from the reference point, 
the scope can be rotated to the left lateral position then slowly withdrawn until the 
left pulmonary artery is visualized, if the scope is withdrawn more, the arch of aorta 
can be visualized. Station 4L is any node that is below the upper border of the arch 
of aorta in that view and above the upper rim of the main pulmonary artery. The 
second approach involves rotating the scope posteriorly from our reference point 
anticlockwise; the descending aorta can be seen as a hypoechoic elongated structure. 
The descending aorta can be followed upward until it starts to disappear. This is the 
level of the arch, which can be followed through its course at that point by rotating 
anteriorly (clockwise). Once the arch is identified, advancing the scope caudally will 
identify the station 4 lymph nodes and left pulmonary artery, see Figure 6.
6.1.4 Station 5
Anatomic definition:
Superiorly limited by the lower border of the aortic arch and inferiorly by the 
upper rim of the left main pulmonary artery. Note that this station is lateral to 
ligamentum arteriosum, while station 4L is medial to that ligament.
Conventional name:
Subaortic (aorto-pulmonary window) lymph nodes.
EUS location:
This lymph node station can be identified using the same technique for the 
station 4L. The only difference is that the station 5 lymph nodes are those that are 
deeper to the ligamentum arteriosum and below the lower rim of the aortic arch. 
The ligamentum arteriosum, when visible, is identified as an elongated hyperechoic 
Figure 6. 
Red star is the aorta, blue arrow (mass/ LN at station 5), orange cross is station 4L, green is the ligamentum 
arteriosum separating 4L from station 5. Note: on US view that the ligamentum arteriosum can be seen as 
dense, hyper-echoic structure connecting the inferior border of aorta to the pulmonary artery.
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structure connecting the left pulmonary artery to the aortic arch (Figure 6). It is 
important to mention here that sometimes, one is faced with large lymph nodes or 
conglomerate of nodes in this position; the differentiation between 5 and 4L can be 
difficult. In our opinion, both stations carry the same staging implication if positive 
for lung cancer (both are N2 or N3 disease, never N1) and the clinical benefit of 
separating the two stations becomes minimal (this issue remains controversial), see 
Figure 6.
Note: Video (https://mts.intechopen.com/download/index/process/324/
authkey/bb9c02ba5640a4d21d4511e0a79f3621) shows EUS-B scope looking 
posteriorly from the reference point identifying the descending aorta; the 
scope is withdrawn rostral while following the descending aorta. Once it starts 
to disappear, the arch is reached. At that point, rotation clockwise to follow 
the arch is performed. Positioned approximately in the middle of the arch, the 
scope is pushed slightly caudally until the left pulmonary artery is identified. 
Station 4L and station 5 are between the arch and the pulmonary artery. The 
former is closer to the probe and the latter is beyond the echogenic ligamentum 
arteriosum.
6.1.5 Station 2
Anatomic definition:
Superiorly, it is limited by apex of lungs and pleural cavity and upper border 
of the manubrium on both sides. Station 2R is limited inferiorly by Intersection of 
caudal margin of the innominate vein and trachea, while on the left (2L) is inferi-
orly limited by the upper border of the aorta.
Conventional name:
Upper paratracheal.
EUS location:
The 2L station are identified by same maneuvers as station 4L, once the aortic 
arch is identified, withdrawing the scope to above the aortic arch identifies sta-
tion 2L location, this station extends all the way up to the level of the manubrium 
anteriorly and the apex of the lung, both are hard to identify ultrasonographically. 
Station 2R is slightly different. Station 2R is the lymph node station that is above the 
level of the brachiocephalic vein and trachea intersection. Once the aortic arch is 
identified, close attention needs to be paid to the vessels sprouting from it, the most 
anterior one is the right brachiocephalic artery, this can be followed anteriorly and 
once sight is lost, it is crossing the trachea. At that point, rotation to the right can 
be done; station 2R lymph nodes are above that point. It should be noted that this is 
not an accurate localization (since we cannot identify the BC vein), but it is the best 
approximation that we could attain.
6.1.6 Station 3p
Anatomic definition:
Limited superiorly by the apex of the lungs and extends inferiorly to the level of 
the carina.
Conventional name:
Retrotracheal.
EUS location:
From the reference point, one can withdraw the scope until right above the 
level of station 7. The scope is then turned posteriorly. All posterior lymph nodes 
(mostly with a slight rotation to the right) are considered 3p up to the upper 
esophagus.
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6.2 Adrenal glands
Anatomic definition:
The adrenal glands represent the fourth most common site of metastasis for 
lung cancer. Identifying left adrenal gland is easier than the right. The right adrenal 
gland cannot be reached by EUS-B. The left adrenal gland is the more common site 
of adrenal metastasis and easily accessible from the stomach. The endoscopist can 
identify his presence in the stomach from identification of the stomach folds under 
US guidance and by visualization of the walls. Several reports of successful biopsy 
of the left adrenal gland have been described [26, 27], Figure 7.
7. Complications
Most of the data available here comes from the literature studying regular endo-
scopic devices. Endoscopy has proven to be a safe procedure. The rates of complica-
tions are probably comparable to that of bronchoscopy. These complications can be 
classified into two main categories.
7.1 Conscious sedation/anesthesia related
Oxygen desaturation (defined as 4% decrease in hemoglobin saturation below 
the baseline) can occur in up to 70% of cases without oxygen supplementation 
[28]. Desaturations occur in both sedated and non-sedated patients. Sedation 
significantly increases the risk of hypoxia [29]. Supplementary oxygen via nasal 
cannula reduces the risk [29, 30]. Difficult intubation, therapeutic procedures, 
increasing age of the patient, and concurrent pulmonary diseases all increase the 
risk of these events [31, 32]. It is not known if mild desaturations (a drop of 4% on 
the pulse oximeter) are clinically significant or not. Severe desaturations (pulse 
oximetry <90%) are less common and can be abolished by the use of supplemental 
oxygen [28, 32, 33]. The ASGE recommends the use of continuous monitoring 
devices (pulse oximetry) to monitor for desaturations and correction of hypoxia. 
Figure 7. 
Once in the stomach, looking posteriorly, one can identify the left adrenal gland (arrow).
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Cardiac complications during endoscopy are also commonly seen and range from 
mild arrhythmias to severe hypotension and cardiac arrest. Tachycardia is probably 
the most common arrhythmia seen [28]. A vasovagal response or discomfort from 
insertion of the scope can be the cause of such a response. Hypotension related to 
the sedation can also be seen. This can also result from the vasovagal response due 
to gas insufflation (which is not used during EUS-B).
7.2 Procedure related
Procedure-related complications of esophagoscopy are rare. The major compli-
cations of diagnostic esophagoscopy include bleeding, perforation, and infection 
[28]. Rarely, it would cause strictures or ulcerations. Most of the available literature 
for EUS-B is from studies evaluating EUS and EUS-FNA of the upper GI tract. Very 
few studies using EUS-FNA for purpose of lung cancer staging are available. These 
generally do not comment on rate or types of complications.
Infections can be related to inadequate equipment disinfection, which can be 
avoided by following the manufacturer guidelines. Another form of infection is the 
introduction of bacteria to the blood stream or a sterile space (the mediastinum in 
case of EUS/B-FNA). Episodes of transient bacteremia are a well-known occurrence 
after upper GI endoscopy (up to 8% of patients) [34]. This is similar for EUS and 
EUS-FNA according to few reports [35]. Most of these episodes of bacteremia are 
transient and asymptomatic. Infectious endocarditis is extremely rare (1–5 × 10−6). 
Prophylactic antibiotics are not necessary for EUS-FNA, unless a cystic mediastinal 
structure is being sampled [34]. Febrile episodes after endoscopy are also common 
(about 1%) and are usually transient. Retropharyngeal abscesses have been reported 
after conventional endoscopy. Isolated reports of benign mediastinal cyst infection 
have been reported to follow EUS-FNA of these structures [36–38]. The risk for 
these infections seems to be very small, but one should be aware of the possibility 
[34]. The ASGE recommends prophylactic antibiotics at time of aspiration and for 
3 days.
Perforation of the esophagus with EUS is a known but rare complication 
(0.03%). Most of the reported data is on radial ultrasonic probes, and limited data 
exist on the curvilinear probes. It seems that esophageal cancer, stricture, increased 
age of patient, and an operator with <1 year experience are independent risk factors 
for perforation [34].
Bleeding occurring can be intra-luminal or extra-luminal. While mild intra-
luminal bleeds after EUS-FNA is a relatively common and expected occurrence (up 
to 4% in one report); extra-luminal bleeding is relatively rare or under-reported 
due to difficulty in diagnosis [34, 39]. The only reported cases of mediastinal bleed-
ing for sampling of lymph nodes for cancer staging was after a transaortic approach 
to periaortic lymph nodes (station 6) [40].
8. Contraindications
As for any other technology or procedure, common sense should prevail. If the 
benefits of the procedure outweigh the risk, then the procedure is probably indi-
cated. We feel that, when present, certain diseases should be avoided and probably 
considered as contraindications. Esophageal stricture greatly increases the risk of 
perforation especially that the EUS-B is inserted and maneuvered blindly inside 
the esophagus. A recent report suggests that the use of EUS-B in the presence of 
esophageal stricture might be safe. The smaller diameter of the scope enabled 
the operators to bypass the stricture and attain diagnostic materials in the cases 
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examined [41]. Esophageal varices and portal hypertension should also be consid-
ered a contraindication due to the increased risk of bleeding from trauma to the 
varices. Coagulopathy needs to be corrected and active GI bleeding is a contraindi-
cation to this procedure. We believe this procedure should only be performed where 
back up GI or general surgery expertise is available, in case a complication arises.
9. Summary
In this review, we have tried to lay out an overview of EUS-B. EUS-B is a natural 
sequel to EBUS for the interventional pulmonologist diagnosing thoracic disease. 
EUS/B offers access to some nodes not accessible to EBUS, and to paraesophageal 
masses, which are not also paratracheal. The esophagus is not housed in cartilagi-
nous rings and structures, a factor, which may make some high thoracic lesions 
accessible to EUS-B alone. As with EBUS, FNA via the esophagus has an extremely 
low rate of complications. EUS-B does not directly impair respiration. In some 
cases, EBUS and EUS-B are appropriately performed concurrently, affecting an 
economy of time, expense, and sedation risks. In short, EUS-B is complementary 
to EBUS and should be integrated into the diagnostic armamentarium of interven-
tional pulmonology.
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